Barak Cohen and Michael Bleicher’s CBD update on a FDA report to Congress was cited by Law.com*, in the article "FDA Seeks More CBD Data," with respect to the agency’s ongoing enforcement approach to regulating the growing market for CBD products.

"The move follows the FDA’s submission of a report to Congress this month that, as a Perkins Coie alert put it, 'echoes the hard-line approach to CBD safety that the agency took on Nov. 25, 2019, when it announced that CBD is not ‘generally recognized as safe’ among qualified experts for use in human or animal food,' but, importantly for CBD businesses, also confirms agency interest in developing a risk-based enforcement approach in order to keep up with the burgeoning market for CBD products.”

*Subscription-based publication.